Cargando…
Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – An AZURE (BIG 01/04) sub-study
PURPOSE: Adjuvant bisphosphonates have been shown to improve disease outcomes in early breast cancer in women who are postmenopausal at the start of treatment. We explored the influence of pretreatment serum levels of reproductive hormones in the hypothalamic-pituitary-gonadal (HPG) axis from a subs...
Autores principales: | Wilson, Caroline, Hinsley, Samantha, Marshall, Helen, Cameron, David, Bell, Richard, Dodwell, David, Coleman, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715229/ https://www.ncbi.nlm.nih.gov/pubmed/29234591 http://dx.doi.org/10.1016/j.jbo.2016.10.005 |
Ejemplares similares
-
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
por: Coleman, R.E., et al.
Publicado: (2018) -
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
por: Brown, Janet, et al.
Publicado: (2018) -
Processing big data with Azure HDInsight: building real-world big data systems on Azure HDInsight using the Hadoop ecosystem
por: Yadav, Vinit
Publicado: (2017) -
Cyber Security on Azure: An IT Professional's Guide to Microsoft Azure Security
por: Copeland, Marshall, et al.
Publicado: (2020) -
Cyber security on Azure: an IT professional's guide to Microsoft Azure Security Center
por: Copeland, Marshall
Publicado: (2017)